Increased membership of women with ASC in the steroidopathic class, which had high posterior probabilities for symptoms known to reflect circulating androgen levels, is consistent with elevated LH and bioavailable testosterone in women with ASC[7]. This evidence concerns the gene PLOD1 and Tako-tsubo cardiomyopathy.